DESCRIPTION OF HEMOGLOBIN LEVELS IN PULMONARY TUBERCULOSIS PATIENTS AT THE TOTO KABILA REGION AL GENERAL HOSPITAL (RSUD), BONE BOLANGO DISTRICT
DOI:
https://doi.org/10.47918/0adk3f22Kata Kunci:
pulmonary tuberculosis; hemoglobin; anemia; iron metabolism; hematological abnormalities.Abstrak
Pulmonary tuberculosis (TB) is a major infectious disease and remains one of the leading causes of morbidity and mortality worldwide. Anemia is a common hematological complication of TB resulting from chronic inflammation, impaired iron metabolism, and reduced erythropoiesis, which may adversely affect treatment outcomes. This study aimed to describe the hemoglobin levels of pulmonary tuberculosis patients treated at Toto Kabila Regional General Hospital, Bone Bolango Regency. A quantitative descriptive study with a cross-sectional design was conducted in May 2025. Thirty pulmonary tuberculosis patients receiving anti-tuberculosis treatment were included using total sampling. Hemoglobin concentrations were measured using an automated hematology analyzer. Data were analyzed descriptively and presented as frequencies, percentages, means, and standard deviations. Among the 30 participants, 56.7% were male and 43.3% were female, with a mean age of 47.17 ± 18.82 years. Moderate anemia was the most prevalent condition (63.3%), while severe anemia and mild anemia each accounted for 6.7%. Only 23.3% of patients had normal hemoglobin levels. The mean hemoglobin concentration was 10.09 ± 1.96 g/dL (range: 7.3–14.2 g/dL). All patients were receiving anti-tuberculosis therapy, whereas only 16.7% received iron supplementation. Anemia, predominantly moderate anemia, was highly prevalent among pulmonary tuberculosis patients. Routine hemoglobin assessment should be integrated into tuberculosis management to facilitate early detection and appropriate management of hematological abnormalities.
Referensi
[1] T. Kurasawa, “[Epidemiology of tuberculosis in the world and Japan].,” Nihon Rinsho., vol. 69, no. 8, pp. 1351–1355, 2011, [Online]. Available: https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053443939&partnerID=40&md5=9e39588b250491f268d306f4c464932f
[2] X. Xiong and F. Zhong, “Global, Regional, and National Burden and Trends of Tuberculosis Among Children and Adolescents From 1990 to 2021: A Comparative Analysis of Drug-Susceptible and Multidrug-Resistant Tuberculosis With Projections to 2045,” J. Paediatr. Child Health, vol. 62, no. 1, pp. 23–34, 2026, doi: 10.1111/jpc.70227.
[3] D. Gninafon, B. Li, X.-W. Zhao, and Q.-Y. Xiu, “Worldwide trends in epidemiology and control of tuberculosis,” Acad. J. Second Mil. Med. Univ., vol. 27, no. 3, pp. 303–310, 2006, [Online]. Available: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645472669&partnerID=40&md5=b33d6cf2b6c9887f261e1b4273e38f5b
[4] C. I. Cercamondi et al., “Iron homeostasis during anemia of inflammation: a prospective study of patients with tuberculosis,” Blood, vol. 138, no. 15, pp. 1293–1303, 2021, doi: 10.1182/blood.2020010562.
[5] J. Hella et al., “Anemia in tuberculosis cases and household controls from Tanzania: Contribution of disease, coinfections, and the role of hepcidin,” PLoS One, vol. 13, no. 4, 2018, doi: 10.1371/journal.pone.0195985.
[6] A. Nienaber, M. A. Uyoga, R. C. Dolman-Macleod, and L. Malan, “Iron Status and Supplementation during Tuberculosis,” Microorganisms, vol. 11, no. 3, 2023, doi: 10.3390/microorganisms11030785.
[7] B. A. Bashir et al., “Role of Iron Indices in Anemia in Patients With Pulmonary Tuberculosis,” Interdiscip. Perspect. Infect. Dis., vol. 2025, no. 1, 2025, doi: 10.1155/ipid/2583917.
[8] F. O. Demitto et al., “Impact of Persistent Anemia on Systemic Inflammation and Tuberculosis Outcomes in Persons Living With HIV,” Front. Immunol., vol. 11, 2020, doi: 10.3389/fimmu.2020.588405.
[9] S. Sulochana, V. Subhashini, and C. Srinivasan, “Pulmonary tuberculosis - A prospective analysis of hematological changes,” Asian J. Pharm. Clin. Res., vol. 11, no. 4, pp. 169–172, 2018, doi: 10.22159/ajpcr.2018.v11i4.23177.
[10] N. M. Reddy, “Studies on clinical parameters of patients suffering from pulmonary tuberculosis,” J. Pure Appl. Microbiol., vol. 9, no. 1, pp. 797–801, 2015, [Online]. Available: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930016198&partnerID=40&md5=cce03ec2cdf9304250979f7fd7100912
[11] E. Sembiring, “THE EFFECT OF BEETROOT BISCUITS (Beta vulgaris) ON THE HEMOGLOBIN LEVEL OF PATIENTS WITH PULMONARY TUBERCULOSIS,” Indones. J. Public Heal., vol. 16, no. 1, pp. 43–55, 2021, doi: 10.20473/ijph.v16i1.2021.43-55.
[12] B. Liu, L. Liu, L. Li, G. Li, and Y. Liu, “Pulmonary Tuberculosis,” in Radiology of Infectious and Inflammatory Diseases - Volume 3: Heart and Chest, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China: Springer Nature, 2023, pp. 169–194. doi: 10.1007/978-981-99-4614-3_16.
[13] F. A. H. Mejbel, I. A. J. Aljanaby, K. K. Al Hadrawi, and A. A. J. Aljanaby, “Pulmonary tuberculosis risks and challenges,” in E3S Web of Conferences, R. D.V., O. A.V., P. E.N., and O. M.Yu., Eds., Department of Biology, Faculty of Science, Uni1versity of Kufa, Iraq: EDP Sciences, 2023. doi: 10.1051/e3sconf/202338101101.
[14] M. Ulfa, W. Purnomo, and R. Indawati, “Factors that affect on the event of lung TB in Jati Kudus health center,” Indian J. Forensic Med. Toxicol., vol. 15, no. 1, pp. 1254–1259, 2021, doi: 10.37506/ijfmt.v15i1.13588.
[15] C. Xu and H. Luo, “Risks of Tuberculosis Prevention and Control,” in Prevention and Control of Infectious Diseases in BRI Countries, Chinese Center for Disease Control and Prevention, Beijing, China: Springer Singapore, 2021, pp. 63–70. doi: 10.1007/978-981-33-6958-0_5.
[16] S. Popović Grle, J. Tekavec-Trkanjec, M. Alilović, and V. Katalinić-Janković, “Pulmonary tuberculosis,” Infektoloski Glas., vol. 33, no. 2, pp. 65–71, 2013, [Online]. Available: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84921987273&partnerID=40&md5=61cc282faf10544b28b7de84b8bc962e
[17] S. Ramadhany, H. Achmad, M. F. Singgih, Y. F. Ramadhany, N. H. Inayah, and N. Mutmainnah, “A review: Knowledge and attitude of society toward tuberculosis disease in soppeng district,” Syst. Rev. Pharm., vol. 11, no. 5, pp. 57–62, 2020, doi: 10.31838/srp.2020.5.10.
[18] S. Płaneta, D. Bartusik-Aebisher, and D. Aebisher, “Hemoglobin,” in The Biochemical Guide to Proteins, Medical College of The University of Rzeszów, Rzeszów, Poland: Nova Science Publishers, Inc., 2023, pp. 117–121. [Online]. Available: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85163602646&partnerID=40&md5=ddb24aeefbb4fcd9304afdde26446187
[19] R. Al-Taweel, D. Burshaid, and S. Al-Turky, “Pulmonary tuberculosis associated with autoimmune hemolytic anemia,” Bahrain Med. Bull., vol. 39, no. 3, pp. 187–188, 2017, doi: 10.12816/0047642.
[20] J. Tupý and I. Solovič, “Anemia associated with tuberculosis – characteristics under conditions of initial iron deficiency,” Stud. Pneumol. Phthiseologica, vol. 82, no. 1, pp. 4–12, 2022, [Online]. Available: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85170391186&partnerID=40&md5=89dffe0ffffcb7fd93a74686d820a05c
[21] M. Kaplan et al., “Serum prohepcidin in pulmonary tuberculosis,” Hematology, vol. 14, no. 4, pp. 245–248, 2009, doi: 10.1179/102453309X439764.
[22] S. R. Kaushik et al., “Low circulatory Fe and Se levels with a higher IL-6/IL-10 ratio provide nutritional immunity in tuberculosis,” Front. Immunol., vol. 13, 2023, doi: 10.3389/fimmu.2022.985538.
[23] L. Fu et al., “Global, Regional, and National Burden of Tuberculosis Among Children: A Population-Based Study,” Trop. Med. Infect. Dis., vol. 11, no. 2, 2026, doi: 10.3390/tropicalmed11020043.
Unduhan
Diterbitkan
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2026 Journal of Health, Technology and Science (JHTS)
Artikel ini berlisensi Creative Commons Attribution 4.0 International License.
